48 studies found for: Open Studies | "Neurofibromatoses"
Neurofibromatosis Type 1 Patient Registry
Resiliency Training for Adolescent Neurofibromatosis Patients Via Videoconferencing With Skype
Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma
Efficacy of Computerized Cognitive Training and Stimulant Medication in Neurofibromatosis Type 1
|5||Not yet recruiting||
Vitamin D Supplementation for Adults With Neurofibromatosis Type 1 (NF1)
Photodynamic Therapy for Benign Dermal Neurofibromas
Neurofibromatosis (NF) Registry Portal
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (PNs)
Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas That Cannot Be Removed by Surgery
Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain
|13||Not yet recruiting||
Resiliency Training for Patients With NF2 Via Videoconferencing With Skype
Effect of Lamotrigine on Cognition in NF1
Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1
Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas
AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.
Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma
† Study has passed its completion date and status has not been verified in more than two years.